C
Chengdu Qi Carbon Technology
Fourth-generation nanopore gene sequencers and consumables manufacturer
About Chengdu Qi Carbon Technology
Chengdu Qi Carbon Technology, also known as Qitan Tech, is a developer and manufacturer operating in the upstream segment of the gene sequencing industry. The company was established in September 2016 and is a collaborative effort by its founders, CEO Dr. Hu Geng, Dr. Xie Dan, and Chief Scientist Dr. Bai Jingwei. Dr. Bai, a Tsinghua University researcher, holds a Ph.D. in Materials Science from UCLA and has over a decade of experience in micro-nano device development, which is central to the company's technology.
The company's business model is centered on the research, development, manufacturing, and sale of nanopore gene sequencers, which represent the fourth generation of sequencing technology. This includes providing the core instruments as well as the accompanying proprietary consumables like sequencing chips (Qcells), reagents, and a one-stop data analysis platform. By supplying these foundational tools, Qitan Tech enables downstream clients to build out their own applications, positioning itself as a platform-level enterprise. Revenue is generated from the sale of these instruments and recurring sales of the necessary consumables. The company serves a diverse client base that includes hundreds of institutions such as disease control and prevention centers, hospitals, universities, and scientific research institutes.
Qitan Tech broke significant ground by developing China's first domestically-produced nanopore gene sequencer, addressing a critical dependency on foreign technology in the Chinese market. Its first commercial product, the QNome-3841, was launched in December 2021, marking the company's transition from R&D to commercialization. This instrument is a small-throughput sequencer noted for its portability and ability to deliver real-time results, making it suitable for applications that require rapid turnaround without the need to batch samples, such as in-field pathogen detection. Since then, the product line has expanded to include models like the QNome-3841hex and the portable, palm-sized QPursue-6k, which offers a medium throughput to support more data-intensive applications like large genome sequencing. The company has also established a production base in Chengdu's Tianfu International Bio-town, capable of annually producing 2,000 sequencers and one million sets of配套 chips and kits.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Chengdu, China
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 41.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Genetics and genomics, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Dec 2023 | $14M | $688M | Chengdu High-tech Ceyuan Capital · Chengdu Bio-Town Investment | ↗ |
| SERIES COther financing | Dec 2022 | $96M | $578M | Alwin Capital · Meituan · Huagai Capital · BioTrack Capital | ↗ |
Growth signals
Latest recorded traffic for Chengdu Qi Carbon Technology is 200 monthly website visits, down 41.2% over the last three months. Chengdu Qi Carbon Technology's team grew 16.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- EIEmpower Investment
Series A11 investors entered at this stage
Baidu Ventures
- TFTsinghua Technology Transfer Fund
- QPQmangel Investment Partnership
- YCYinxinggu Capital
CDH Investments
Hillhouse Capital
Gaorong Capital
Riverhead Capital
GL Ventures
BioTrack Capital
Huagai Capital
Series B and later4 investors entered at this stage
- ACAlwin Capital
Meituan- CCChengdu High-tech Ceyuan Capital
- CIChengdu Bio-Town Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Chengdu Qi Carbon Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Chengdu Qi Carbon Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







